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’ Full Report
Mrgprs activation is required for chronic itch
conditions in mice
Yuyan Zhu, PhDa, Claire E. Hanson, BSca, Qin Liu, PhDb, Liang Han, PhDa,,*

Introduction: Chronic itch has been drawing much attention due to its clinical signiﬁcance and the complexity of its mechanisms.
To facilitate the development of anti-itch strategies, it is necessary to investigate the key players in itch sensation under chronic itch
conditions. Several members of the Mrgpr family were identiﬁed as itch receptors that detect cutaneous pruritogens in primary
sensory neurons. However, the role of Mrgprs in chronic itch conditions has not been well described.
Methods: Scratching behaviors of Wildtype and Mrgpr-clusterΔ − / − mice were examined in dry skin model and contact dermatitis
model to examine the role of Mrgpr genes in mediating chronic itch sensation. Scratching behaviors of the mice were also examined in
allergic itch model. Real-time polymerase chain reaction were performed to examine the expression level of MrgprA3 and MrgprC11
under naive and dry skin conditions. The MrgprA3 + itch-sensing ﬁbers were labeled by tdTomato ﬂuorescence in Mrgpra3GFP-Cre;
ROSA26tdTomato mice, and the morphology and density of those ﬁbers in the epidermis were analyzed under dry skin condition.
Results: We showed that deleting a cluster of Mrgpr genes in mice reduced scratching behavior severely under 2 chronic itch
conditions, namely dry skin and contact dermatitis, and the allergic itch condition. Moreover, the gene expressions of itch receptors
MrgprA3 and MrgprC11 in dorsal root ganglia were upregulated signiﬁcantly under dry skin condition. Consistently, the percentage of
MrgprA3 + itch-sensing neurons was increased as well. We also observed hyperinnervation of MrgprA3 + itch-sensing ﬁbers in the
epidermis of the skin under dry skin condition.
Discussion: We demonstrate that Mrgprs play important roles in mediating chronic itch and allergic itch. These ﬁndings enrich our
knowledge of itch mechanism and may lead to the development of novel therapeutic approach to combat itch.
Keywords: Chronic itch, MrgprA3, MrgprC11, Skin

Recent studies have identiﬁed several members of the Mrgpr
(mas-related G-protein coupled receptor) family as new itch
receptors[8–12]. The Mrgpr family consists of > 20 functional
members that are grouped into several subfamilies: MrgprA1-22,
MrgprB1-13, MrgprC1-14, and MrgprD-G. Among them,
MrgprA3, MrgprC11, and MrgprD have been identiﬁed as itch
receptors that are speciﬁcally expressed in small-diameter sensory
neurons and directly detect pruritogens in the skin[9,11,12].
MrgprA3 is the receptor for chloroquine, a drug used to treat
malaria and generates itch as a side effect. MrgprC11 is the
receptor for pruritogen bovine adrenal medulla 8–22 peptide
(BAM8–22) and SLIGRL. β-alanine, a muscle building supplement that frequently elicits itch in human, acts through MrgprD.
Moreover, the expression of MrgprA3 deﬁnes a subset of
nociceptors that speciﬁcally mediate itch, but not pain[13]. These
neurons express multiple itch receptors including MrgprA3,
MrgprC11, and histamine receptor 1, and correspondingly
respond to multiple pruritogens. Deletion of MrgprA3 + sensory
neurons signiﬁcantly inhibits itch behavior not only in acute itch
conditions[14], but also in chronic itch conditions[13,15], demonstrating that this neuronal population is crucial for mediating itch
sensation. However, whether the chronic itch response requires
the activation of Mrgprs in MrgprA3 + neurons is unknown.
Here we show that the scratching behaviors evoked under 2
chronic itch conditions, namely dry skin and contact dermatitis,
were signiﬁcantly suppressed in Mrgprs-deﬁcient mice. We also
found that allergen-induced scratching behaviors were reduced
after the deletion of Mrgprs. Moreover, dry skin chronic itch
condition increased the expression of itch receptors MrgprA3 and

Introduction
Chronic itch accompanying cutaneous disease or systemic disorders is a serious condition[1–3]. In older adults, xerosis (aka dry
skin), a common skin problem, usually causes pruritus, and the
scratching response results in a high risk of secondary infection in
skin[4]. Patients with advanced renal disease and liver disease
frequently report pruritus as a common symptom[2,3]. The persistent itching signiﬁcantly affects patients’ quality of life[5–7].
Despite its clinical importance, the molecular and cellular
mechanisms of chronic itch are largely unknown.
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MrgprC11. We observed for the ﬁrst time that dry skin condition
induced the hyperinnervation of MrgprA3 + itch-sensing ﬁbers in
the epidermis. Taken together, we demonstrate that Mrgprs play
a critical role in mediating chronic itch and allergic itch.

Real-time polymerase chain reaction (RT-PCR)

All experiments were performed with approval from the Georgia
Institute of Technology Animal Use and Care Committee. The
generations of Mrgpr-clusterΔ − / − mice and Mrgpra3GFP-Cre mice
were described previously[12,13]. ROSA26tdTomato mouse line was
purchased from Jackson Laboratory. All the mice used had been
backcrossed to C57BL/6 mice for at least 10 generations. 2- to
3-month-old males (20–30 g) were used for all experiments. Mice
were housed in the vivarium with 12-hour-light/dark cycle, and
all the behavioral tests were performed from 9 AM to 1 PM in the
light cycle. The housing group was 5 at maximum with food and
water ad libitum.

Dorsal root ganglia (DRG) innervating the dry skin–treated area
(C3–T10) were collected from the trunk region of mice and total
RNA was extracted from the ganglia using the RNeasy Micro Kits
(Qiagen) according to the manufacturer protocol. RNA was
reverse-transcribed into cDNA using SuperScript III First-Strand
Synthesis System (Invitrogen). Quantitative RT-PCR was performed using a StepOnePlus Real-Time PCR System (Thermo
Fisher Scientiﬁc) with the SYBR Green detection method. The cycle
threshold (CT) values were analyzed by the 2 − ΔCt method to
determine the normalized expression ratio of target genes. β-actin
expression level was used as the internal control. The intronspanning primers used are listed here: β-actin-F, AGCTGTGC
TATGTTGCTCTAG, β-actin-R, AGGTCTTTACGGATGTCAA
CG, MrgprA3-F, ACACAAGCCAGCAAGCTACA, MrgprA3-R,
ACTTCCAGGGATGGTTTCGT, MrgprC11-F, AGCATCCACA
ACCCCAGAAG, MrgprC11-R, TGGAGTGCAGTTGGGATGAC.
TRPV1-F, ATCATCAACGAGGACCCAGG. TRPV1-R, TGCTAT
GCCTATCTCGAGTGC.

Scratch assay

Quantiﬁcation of itch-sensing neurons and ﬁbers in the skin

All procedures were performed using protocols approved by the
Animal Care and Use Committee of Georgia Institute of
Technology. The experiments were performed as previously
described[13]. Brieﬂy, the day before the scratch assay, all the mice
were acclimated for at least 30 minutes to their testing environment. During scratch assay, mice were kept in plastic cylinders
individually and the behavioral responses were video recorded
for 30–60 minutes. The video recording was subsequently played
back in a slow motion and the number of bouts of scratching with
the hindpaw were counted. All behavioral tests were performed
by an experimenter blind to the genotypes of the mice.

After 6 days of dry skin treatment, MrgprA3GFP-Cre;
ROSA26tdTomato mice were anesthetized with pentobarbital and
perfused with PBS (pH 7.4, 4°C) followed with 4% paraformaldehyde (4°C). DRG innervating the treated skin (C3–T10)
were dissected from the perfused mice. DRG were postﬁxed in
4% paraformaldehyde at 4°C for 30 minutes. Treated skin were
dissected and ﬁxed in 2% paraformaldehyde at 4°C overnight.
All tissues were cryoprotected in 20% sucrose in PBS at 4°C for
24 hours, and frozen in Optimal cutting temperature at − 80°C.
Tissues were sectioned at 20 μm with a Cryostar NX50 Cryostat
(Thermo Fisher scientiﬁc). The sections on slides were dried at 37°
C for 30 minutes, and ﬁxed with 4% paraformaldehyde at room
temperature for 10 minutes. The slides were washed with PBS,
and the ﬂuorescence labeled neurons or skin ﬁbers were visualized and quantiﬁed under ﬂuorescent microscope. Totally
3000–8000 sensory neurons from each mouse were counted to
quantify the percentage of tdTomato labeled MrgprA3 + neurons.
Cell nuclei in the skin sections were stained with 4’,6-diamidino2-phenylindole to visualize the epidermis. Skin sections (10–22)
were analyzed to quantify the intraepidermal density of
tdTomato labeled MrgprA3 + skin ﬁbers. n = 3 for both naive
group and dry skin–treated group.

Experimental procedures
Animals

Three itch conditions
Dry skin pruritus[16]
The shaved back skin of a mouse was treated with an acetone/
ether (1:1) mixture for 15 seconds followed by distilled water
(Acetone, Ether and Water) twice daily for 6 days to generate skin
dehydration. On day 7, mice were recorded for 60 minutes to
quantify the spontaneous scratching.
Contact dermatitis[17]
A mouse model of contact dermatitis is produced by treating the
skin with an allergen squaric acid dibutylester (SADBE, 25 μL,
0.5% in acetone). On days 1–3, SADBE was applied to the shaved
abdomen once a day to initiate T-lymphocyte sensitization. On
days 8–10, SADBE was applied to the shaved back skin to induce
dermal inﬂammation and spontaneous scratching. On day 12, the
spontaneous scratching behavior was recorded for 60 minutes.

Histologic analysis
The treated skin were collected and ﬁxed in 10% neutralized
formalin for > 24 hours. The skin samples were embedded in
parafﬁn, sectioned at 5 μm, and stained with hematoxylin and
eosin. The hematoxylin and eosin–stained images were taken
using Nikon Ni-U microscopy and DS-Fi2 color camera. At least
10 sections per sample were analyzed. The area of each section to
measure epidermal thickness was randomly picked. The skin
thickness and epidermal thickness were analyzed using Image J.

Allergic itch[18]
Ovalbumin (OVA) (50 μg) dissolved in phosphate-buffered saline
(PBS) was administered intraperitoneally together with 2 mg of
inject Alum twice at a 10-day interval. One week after the second
sensitization, 50 μg of OVA was injected subcutaneously into the
nape of a mouse’ neck to induce acute allergic itch. The scratching
behavior was recorded for 30 minutes.

Statistical analysis
Data are presented as means ± SEM. Statistical analysis was
performed using the Student 2-tailed t test to compare between
groups. P-value <0.05 was considered statistically signiﬁcant.
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Figure 1. Mrgpr genes are required for dry skin itch. A, Hematoxylin and eosin staining of the skin sections collected from WT and Mrgprs clusterΔ − / − mice after dry
skin treatment. B, Dry skin treatment induced comparable increase of the epidermal thickness in WT and Mrgprs clusterΔ − / − mice (n ≥ 10 sections from 3 to 5 mice
per group). C, Mrgprs clusterΔ − / − mice exhibited reduced scratching behavior under dry skin condition. n ≥ 5 for each group. ***P < 0.005. Two-tailed unpaired
Student t test. Error bars represent SEM. Scale bar = 100 μm. WT indicates Wildtype.

collected from Wildtype (WT) and Mrgpr-clusterΔ − / − mice
exhibited similar morphologic changes (Fig. 1A) and comparable
increase of the epidermal thickness (Fig. 1B). These results suggest that the deletion of Mrgpr genes did not affect the development of the dry skin model. Excitingly, Mrgpr-clusterΔ − / − mice
exhibited signiﬁcant decrease in scratching behavior compared
with WT mice (Fig. 1C), suggesting that the activation of Mrgpr
genes are required for dry skin itch.
Contact dermatitis is a condition of skin inﬂammation produced
by unwanted contact with irritant or allergic chemicals. The mouse
model of contact dermatitis is generated by treating the skin with
the allergen SADBE. The treatment generated acanthosis (thickening of the skin), parakeratosis, and dense inﬂammatory cells
inﬁltration in both WT and Mrgpr-clusterΔ − / − mice (Fig. 2A). The
skin thickness is comparable between the 2 groups after the
treatment (Fig. 2B). However, Mrgpr-clusterΔ − / − mice showed a
severe reduction in scratching behavior compared with WT mice
suggesting that Mrgpr genes mediate itch sensation in the contact
dermatitis model (Fig. 2C).

Results
Mrgprs mediate chronic itch and allergic itch
A straightforward way to determine the role of Mrgprs in chronic
itch is to delete Mrgpr genes and see whether scratching behavior
is affected. As many Mrgpr genes in mice are clustered together,
to avoid compensatory effects, Mrgpr-clusterΔ − / − mouse has
been generated previously in which 12 Mrgpr genes including 2
identiﬁed itch receptors, MrgprA3 and MrgprC11, have been
deleted in the mouse genome[12]. We compared the scratching
behavior of wild-type and Mrgpr-clusterΔ − / − mice under 2 different chronic itch conditions: dry skin[16] and contact
dermatitis[17]. Skin dehydration is always accompanied by persistent itchiness of the skin, especially in the elderly[4]. In the
mouse model, the dry skin condition was generated by repetitive
exposure of the skin to the mixture of acetone and ether[16]. The
treatment induced pronounced epidermal hyperplasia and parakerotosis, but did not induce inﬁltration of the inﬂammatory
cells[16]. Histologic analysis demonstrated that the treated skin

Figure 2. Mrgpr genes are required for itch sensation in contact dermatitis model. A, Hematoxylin and eosin–stained skin sections collected from WT and Mrgprs
clusterΔ − / − mice after contact dermatitis treatment. B, WT and Mrgprs clusterΔ − / − mice showed similar increase of skin thickness after contact dermatitis
treatment (n ≥ 10 sections from 3 to 5 mice per group). C, Mrgprs clusterΔ − / − mice exhibited reduced scratching behavior in contact dermatitis model. n ≥ 5 for
each group. ***P < 0.005. Two-tailed unpaired Student t test. Error bars represent SEM. Scale bar = 100 μm. WT indicates Wildtype.
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chloroquine and SLIGRL were increased in the dry skin
model[20,21]. Consistently, we found that the mRNA levels of
MrgprA3 and MrgprC11 were signiﬁcantly increased after the
dry skin treatment (Figs. 4A, B). In the contrary, the expression of
TRPV1, a sensor for noxious heat and pain sensation[22,23], was
not changed in the dry skin model.
Next, we examined whether the percentage of MrgprA3 +
neurons, the previously identiﬁed speciﬁc itch-sensing neurons[13],
increased after the dry skin treatment. Our previous study generated a BAC transgenic mouse line Mrgpra3GFP-Cre to express GFPCre fusion protein in MrgprA3 + neurons[13]. MrgprA3 + neurons
were labeled with tdTomato ﬂuorescence by crossing the
Mrgpra3GFP-Cre line with a Cre-dependent ROSA26tdTomato line
(Fig. 5A). We collected the DRG sections from the Mrgpra3GFP-Cre;
ROSA26tdTomato mice with or without dry skin treatment, and
found that the percentage of tdTomato labeled MrgprA3 + neurons from dry skin–treated mice was signiﬁcantly higher than that
from control animals (Fig. 5B). Collectively, our data demonstrated that the dry skin condition enhanced the expression of
MrgprA3 and MrgprC11 and expanded the expression of
MrgprA3 into a broader sensory neuron population.

Figure 3. Mrgprs clusterΔ − / − mice exhibited reduced allergic itch behavior.
n ≥ 5 for each group. *P < 0.05. Two-tailed unpaired Student t test. Error bars
represent SEM.

We next examined whether Mrgprs are involved in acute
allergen-induced itch sensation. In the allergic itch mouse model,
the allergen OVA was administered intraperitoneally twice,
10 days apart, to sensitize the mice. Injection of OVA subcutaneously 1 week after the second sensitization induced acute
allergic responses and scratching behavior directed to the injected
site. We found that Mrgpr-clusterΔ − / − mice exhibited signiﬁcantly less scratching behavior compared with WT littermates
(Fig. 3) under the allergic itch condition. In summary, our data
showed that Mrgprs play a critical role in mediating the itch
sensation in 3 tested itch conditions.

Dry skin condition induces hyperinnervation of MrgprA3 +
itch-sensing ﬁbers in the epidermis
Pruritic skin is often accompanied by alteration of the sensory
innervations in the skin. Skin biopsies from atopic dermatitis
patients showed enhanced intraepidermal ﬁber density labeled by
PGP9.5[24,25]. Dry skin pruritus has been shown to be associated
with an increase of Ret-positive intraepidermal ﬁber density[20].
MrgprA3 + sensory neurons, which constitute about 8% of sensory neurons and exclusively innervate the epidermis of the skin,
are required for mediating itch sensation induced by multiple
pruritogens[13]. Whether and how the MrgprA3 + itch-sensing
ﬁbers are changed in the skin by the chronic itch conditions have
not yet been investigated. With the tdTomato ﬂuorescence labeling
in the neuron, we were able to visualize the periphery projection of
MrgprA3 + itch-sensing ﬁbers in the skin (Figs. 6A–D). Epidermis
in the skin sections was identiﬁed by the morphology of the
keratinocytes labeled by 4’,6-diamidino-2-phenylindole. Consistent

Dry skin condition upregulates the expression of Mrgprs
MrgprA3 and MrgprC11, 2 previously identiﬁed itch receptors,
were among the 12 genes that were deleted in Mrgpr-clusterΔ − / −
mice. Both of them are speciﬁcally expressed in the small-diameter sensory neurons[8,12,13]. MrgprA3 gene expression has
been shown to be upregulated in sensory neurons in the dry skin
model[19]. The percentage of sensory neurons responding to

Figure 4. Dry skin condition upregulates the expression of Mrgpr genes. Real-time polymerase chain reaction results showing that the expression of MrgprA3 (A)
and MrgprC11 (B) were upregulated in the dorsal root ganglia under the dry skin condition. The expression of TRPV1 was not changed (C). n = 3 for MrgprA3 and
TRPV1 and n = 6 for MrgprC11. *P < 0.05. Two-tailed unpaired Student t test. Error bars represent SEM. n.s. indicates not signiﬁcant.
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Figure 5. Dry skin condition increases the percentage of MrgprA3 + itch-sensing neurons in the dorsal root ganglia (DRG). A, DRG sections of Mrgpra3GFP-Cre;
ROSA26tdTomato mice showing the MrgprA3 + neurons labeled by tdTomato ﬂuorescence under control or dry skin condition. tdTomato ﬂuorescent images were
merged with phase contrast images to show the morphology of the DRG sections. B, The percentage of MrgprA3 + neurons in the DRG under control or dry skin
condition. n = 3 for each experiment. ***P < 0.005. Two-tailed unpaired Student t test. Error bars represent SEM. Scale bar = 100 μm.

with previous results, MrgprA3 + ﬁbers were free nerve endings in
the epidermis and terminated in the stratum granulosum, the
superﬁcial layer of the epidermis[13] (Figs. 6A–D). Epidermal
hyperplasia induced by the dry skin treatment can be observed in
dry skin sections but not in control sections (Figs. 6B, D). We found
that the morphology of MrgprA3 + ﬁbers was different under the
chronic itch condition compared with the naive condition. The
ﬁbers from the naive condition normally penetrated the epidermis
to reach the stratum granulosum and did not show ﬁber branches in
the epidermis. However, about 13% of the MrgprA3 + ﬁbers under
chronic itch condition generated branches in the epidermis
(Figs. 6A–E). Moreover, MrgprA3 + intraepidermal ﬁber density
increased signiﬁcantly under dry skin conditions (Fig. 6F). These
data collectively demonstrate that the dry skin condition induced

hyperinnervation of the MrgprA3 + itch-sensing ﬁbers in the
epidermis.

Discussion
Itch sensation is initiated by the activation of sensory nerves in the
skin. Itch receptors expressed in the nerve endings are responsible
for ﬁrst sensing the pruritogens. Among all the itch receptors,
Mrgprs are relatively new but play a critical role in itch sensation.
In this study, we showed that deleting 12 Mrgpr genes in mice
suppressed scratching behavior in 2 chronic itch conditions and
allergic itch condition. We further demonstrate that dry skin
chronic itch condition triggered the active expression of itch
receptors MrgprA3 and MrgprC11 in the DRG sensory neurons

Figure 6. Dry skin condition induces hyperinnervation of itch-sensing ﬁbers in the epidermis. A–D, Skin sections of Mrgpra3GFP-Cre; ROSA26tdTomato mice with (A, B)
and without (C, D) DAPI staining showing the MrgprA3 + ﬁbers labeled by tdTomato ﬂuorescence in the epidermis. The dashed line labels the boundary between
dermis and epidermis. Arrow point to a branched ﬁber in the epidermis of a dry skin section. E, The percentage of MrgprA3 + ﬁbers with branches in the epidermis
under control and dry skin conditions. F, The MrgprA3 + intraepidermal nerve ﬁber (IENF) density under control and dry skin conditions. n = 3 for each experiment.
***P < 0.005. Two-tailed unpaired Student t test. Error bars represent SEM. Scale bar = 20 μm. DAPI indicates 4',6-diamidino-2-phenylindole.
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activity-dependent transcription of itch receptors. These hypotheses need to be tested with further studies.
We have analyzed the morphology and density of itch-sensing
nerve ﬁbers in the epidermis under dry skin condition. MrgprA3 +
itch-sensing neurons only constitute a small percentage of DRG
sensory neurons. Their intraepidermal nerve density is high
enough to sense the potential stimuli in every spot in the skin, but
not too high to prevent the clear visualization and quantiﬁcation
of the nerve ﬁbers and the ﬁber branches. Using Mrgpra3GFP-Cre;
ROSA26tdTomato mouse, we were able to observe the hyperinnervation of the MrgprA3 + itch-sensing ﬁbers under dry skin
conditions (Fig. 6). Notably, this is the ﬁrst time that the morphologic changes of MrgprA3 + itch-speciﬁc ﬁbers under chronic
itch condition have been observed. Both upregulation of itch
receptors and hyperinnervation of itch-sensing ﬁbers might contribute to the hypersensitivity of itchy skin to pruritogens.
Taken together, our data suggest that Mrgprs play an important role in mediating itch sensation in multiple conditions.
Human MrgprX1 is the functional receptor for both CQ and
BAM8–22 and is the functional orthologue for MrgprA3 and
MrgprC11[12,44]. Further studies are required to investigate the
involvement of hMrgprX1 in chronic itch conditions in human
patients and to test the possibility to antagonize hMrgprX1 for
anti-itch treatment.

and the morphologic expansion of itch-sensing nerves in the skin.
Our data highlight the critical role of Mrgprs in mediating
chronic itch and allergic itch.
Clinically, itch is categorized into 4 groups: dermatologic,
systemic, neurological, and psychiatric[26]. Currently, only a
handful of mouse models for itch conditions have been
established[14]. We have used 3 representative dermatologic
mouse itch models in this study, including a nonallergic chronic
itch model (Acetone, Ether and Water-dry skin), an allergic
chronic itch model (SADBE-contact dermatitis), and an allergic
acute itch model (OVA-allergic itch). These 3 models involve
distinct signaling pathways. Dry skin treatment decreases stratum
corneum hydration, induced epidermal hyperplasia, and parakeratosis, but does not induce skin inﬂammation[16] (Figs. 1A, B).
SADBE-contact dermatitis model represents the allergic skin
inﬂammation condition. The challenged skin is inﬁltrated with
inﬂammatory cells and soaked in an inﬂammatory soup of
cytokines and chemokines[27]. OVA-allergic itch model evokes
IgE-dependent mast cell–mediated acute allergic response. OVA
challenge induces the secretion of a variety of mast cell mediators
in the skin to evoke cutaneous anaphylactic symptoms including
itch sensation[28,29]. It is intriguing that our data suggest that
Mrgprs can be activated in 3 different models. As 12 Mrgpr genes
were deleted in the Mrgpr-clusterΔ − / − mice, it is possible that
different Mrgpr genes mediate itch sensation in different conditions. Alternatively, a certain Mrgpr gene may be activated by
different pruritogens produced in different conditions. For
example, MrgprC11 has multiple identiﬁed agonists such as
neuropeptide FF (NPFF), Cathepsin S, and Der p1[12,30–32], all of
which can be good candidates for evoking itch. NPFF is a neuropeptide that can be released from mouse bone marrow–derived
mast cells[30]. It is possible that NPFF is released by the skin mast
cells in the OVA-allergic itch condition and activate MrgprC11 +
nerves. Cathepsin S is associated with inﬂammatory processes
and chronic itch conditions. The expression of cathepsin S is
upregulated in psoriatic keratinocytes[33]. Mice carrying a
transgene expressing cathepsin S spontaneously develop atopic
dermatitis[34]. Der p1 is a prominent allergen from house dust
mite and has been involved in the allergic inﬂammatory processes
in both skin[35,36] and the respiratory system[37]. It will be interesting to examine whether cathepsin S and Der p1 are endogenous agonists for MrgprC11 under the itch conditions we tested.
Patients with chronic itch often display heightened sensitivity to
itchy stimuli, which can be partly attributed to peripheral sensitization of sensory neurons[38–41]. MrgprA3 + sensory neurons are a
major sensory neuron population mediating itch sensation[13].
Consistently, MrgprA3 + neurons exhibit enhanced excitability in
a mouse model of inﬂammatory itch[15]. Here, we used the dry skin
chronic itch model to examine how chronic itch condition change
the MrgprA3 + itch-sensing neurons. We showed that the dry skin
treatment increased the gene expression of MrgprA3 and
MrgprC11, and increased the percentage of MrgprA3 + neurons in
DRG (Fig. 2). The dry skin treatment mainly generates skin barrier
disruption and stratum corneum dehydration. It is very likely that
the mediators secreted by keratinocytes during the treatment
promote upregulation of itch receptors. In addition, neuronal
activity-dependent transcription regulation is a common mechanism used by many neuron types including DRG sensory neurons
for proper development and adaptation during adulthood[42,43].
It is also possible that the continuous activation of MrgprA3 +
itch-sensing neurons under dry skin condition induced the
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